Condition : Osteoarthrosis in Knee-joint Intervention : Procedure: Total Knee Arthroplasty Sponsor : Northern Orthopaedic Division, Denmark Recruiting - verified August 2011

This observational, prospective, open-label, multi-center study will evaluate the effectiveness in disease reduction and the safety of RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthr...

This observational, prospective, open-label, multi-center study will evaluate the effectiveness in disease reduction and the safety of RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthr...

This observational, prospective, open-label, multi-center study will evaluate the effectiveness in disease reduction and the safety of RoActemra/Actemra (tocilizumab) in patients with rheumatoid arthr...

Condition : Rheumatoid Arthritis Interventions : Biological: GP2013; Biological: rituximab Sponsors : Sandoz; Novartis Pharmaceuticals Recruiting - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Dietary Supplement: EPAX 6000 EE 1000mg (0.6 gr DHA+EPA); Dietary Supplement: Capsules (Placebo) Sponsor : Rabin Medical Center Recruiting - verified F...

Condition : Osteoarthritis of the Knee Interventions : Biological: Platelet Rich Plasma (Preparation Rich in Growth Factors); Drug: Hyaluronic acid Sponsor : Meir Medical Center Not yet recruiting - v...

Condition : Rheumatoid Arthritis Interventions : Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Adalimumab and p...

Condition : Rheumatoid Arthritis Interventions : Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Fostamatinib and placebo injections; Drug: Adalimumab and p...

Condition : Rheumatoid Arthritis Interventions : Biological: PDA001; Other: Vehicle Controlled Placebo Sponsors : Celgene Corporation; Celgene Corporation; Celgene Cellular Therapeutics Active, not re...